Tuesday, November 5, 2024
HomeTagsClinical Development

Clinical Development

Deka Biosciences Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application

Deka Biosciences, a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases, announced that the U.S. Food and Drug...

Hemispherian raises the first tranche of a Series A to fund the development of its novel cancer therapeutics

Hemispherian AS, a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce the closure...

CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations

CANbridge Pharmaceuticals, Inc., a China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced...

Engimmune Therapeutics raises CHF 15.5 million in seed financing to develop novel T-cell receptor therapeutics

Engimmune Therapeutics AG ("Engimmune"), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, announced the completion of a CHF 15.5 million (EUR 15.2...

ImmVira Enters Clinical Development in Combination Therapy of MVR-T3011 IT and MEK Inhibitor in the U.S.

ImmVira announced that, company has reached a cooperation agreement with Roche to establish clinical research partnership recently, to conduct clinical studies in the U.S....
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics